HIV Seropositivity

"HIV Seropositivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).

Descriptor ID	D006679
MeSH Number(s)	C02.782.815.616.400.500 C02.800.801.400.500 C20.673.480.500
Concept/Terms	HIV Seropositivity HIV Seropositivity HIV Seropositivities Seropositivities, HIV Seropositivity, HIV AIDS Seropositivity AIDS Seropositivities Seropositivities, AIDS Seropositivity, AIDS Anti-HIV Positivity Anti HIV Positivity Anti-HIV Positivities Positivities, Anti-HIV Positivity, Anti-HIV HTLV-III Seropositivity HTLV III Seropositivity HTLV-III Seropositivities Seropositivities, HTLV-III Seropositivity, HTLV-III HIV Seroconversion HIV Seroconversions Seroconversion, HIV Seroconversions, HIV HTLV-III Seroconversion HTLV III Seroconversion HTLV-III Seroconversions Seroconversion, HTLV-III Seroconversions, HTLV-III AIDS Seroconversion AIDS Seroconversions Seroconversion, AIDS Seroconversions, AIDS HIV Antibody Positivity Antibody Positivities, HIV Antibody Positivity, HIV HIV Antibody Positivities Positivities, HIV Antibody Positivity, HIV Antibody

Below are MeSH descriptors whose meaning is more general than "HIV Seropositivity".

Diseases [C]
Virus Diseases [C02]
RNA Virus Infections [C02.782]
Retroviridae Infections [C02.782.815]
Lentivirus Infections [C02.782.815.616]
HIV Infections [C02.782.815.616.400]
HIV Seropositivity [C02.782.815.616.400.500]
Sexually Transmitted Diseases [C02.800]
Sexually Transmitted Diseases, Viral [C02.800.801]
HIV Infections [C02.800.801.400]
HIV Seropositivity [C02.800.801.400.500]
Immune System Diseases [C20]
Immunologic Deficiency Syndromes [C20.673]
HIV Infections [C20.673.480]
HIV Seropositivity [C20.673.480.500]

Below are MeSH descriptors whose meaning is related to "HIV Seropositivity".

Below are MeSH descriptors whose meaning is more specific than "HIV Seropositivity".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HIV Seropositivity" by people in this website by year, and whether "HIV Seropositivity" was a major or minor topic of these publications.

Bar chart showing 49 publications over 21 distinct years, with a maximum of 9 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	3	0	3
1994	1	0	1
1995	1	0	1
1996	0	1	1
1997	1	0	1
1999	1	0	1
2001	2	0	2
2002	1	1	2
2003	1	1	2
2004	0	2	2
2005	3	0	3
2006	2	1	3
2008	2	1	3
2009	1	0	1
2010	4	0	4
2011	3	1	4
2012	7	2	9
2013	2	0	2
2014	2	0	2
2016	1	0	1
2018	1	0	1

Below are the most recent publications written about "HIV Seropositivity" by people in Profiles.

Pandey JP. HIV-1 Control and Immunoglobulin Genes. J Infect Dis. 2018 03 13; 217(7):1170.

View in: PubMed
Iyer AS, Khaskhely NM, Leggat DJ, Ohtola JA, Saul-McBeth JL, Khuder SA, Westerink MA. Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults. PLoS One. 2016; 11(3):e0150261.

View in: PubMed
Lazenby GB, Unal ER, Andrews AL, Simpson K. Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Sex Transm Dis. 2014 Jun; 41(6):353-8.

View in: PubMed
Hulbert A, Hooker CM, Keruly JC, Brown T, Horton K, Fishman E, Rodgers K, Lee B, Sam C, Tsai S, Weihe E, Pridham G, Drummond B, Merlo C, Geronimo M, Porter M, Cox S, Li D, Harline M, Teran M, Wrangle J, Mudge B, Taylor G, Kirk GD, Herman JG, Moore RD, Brown RH, Brock MV. Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers. J Thorac Oncol. 2014 Jun; 9(6):752-9.

View in: PubMed
Simpson KN, Hanson KA, Harding G, Haider S, Tawadrous M, Khachatryan A, Pashos CL, Wu AW. Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review. Health Qual Life Outcomes. 2013 Oct 03; 11:164.

View in: PubMed
Bynum SA, Wigfall LT, Brandt HM, Richter DL, Glover SH, Hébert JR. Assessing the influence of health literacy on HIV-positive women's cervical cancer prevention knowledge and behaviors. J Cancer Educ. 2013 Jun; 28(2):352-6.

View in: PubMed
Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, Leppo M, Levey AS, Okparavero A, Graham H, Savage K, Schmid CH, Tighiouart H, Wallach F, Krishnasami Z. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr. 2012 Nov 01; 61(3):302-9.

View in: PubMed
Finocchario-Kessler S, Mabachi N, Dariotis JK, Anderson J, Goggin K, Sweat M. "We weren't using condoms because we were trying to conceive": the need for reproductive counseling for HIV-positive women in clinical care. AIDS Patient Care STDS. 2012 Nov; 26(11):700-7.

View in: PubMed
Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, Krishnasami Z, Willig JH, Martin JN, Moore RD, Eron JJ, Kitahata MM. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012 Sep 24; 26(15):1907-15.

View in: PubMed
Fonner VA, Denison J, Kennedy CE, O'Reilly K, Sweat M. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev. 2012 Sep 12; (9):CD001224.

View in: PubMed

People

Explore

Similar Concepts

Top Journals